Moudrý Pavel Ph.D.
About me
Head of the DNA replication dynamics research group at the Institute of Molecular and Translational Medicine.
Scientist with long-term specialization in the DNA replication and DNA damage response.
Author of 16 scientific publications, accumulating more than 1500 citations and H-index of 13.
Mentor for Bachelor, Master, and PhD students.
Positions for talented Master or PhD students keen on exploring DNA replication in normal and cancer cells are available. Feel free to contact me for detailed information.
Journals
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4. Nature. 2017, 552(7684), 194-199, ISSN: 0028-0836, PMID: 29211715,
Perturbation of RNA Polymerase I transcription machinery by ablation of HEATR1 triggers the RPL5/RPL11-MDM2-p53 ribosome biogenesis stress checkpoint pathway in human cells. Cell Cycle. 2017, 17(1), 92-101, ISSN: 1538-4101, PMID: 29143558,
Proteomic profiling reveals DNA damage, nucleolar and ribosomal stress are the main responses to oxaliplatin treatment in cancer cells. Journal of Proteomics. 2017, 162, 73-85, ISSN: 1874-3919, PMID: 28478306,
Open positions
1 Molecular and Translational Medicine
| Project: | Cellular stress in health and disease |
|---|---|
| Supervisors: | Mistrík Martin Ph.D., Moudrý Pavel Ph.D., Škrott Zdeněk Ph.D. |
| Available: | 3 |
| Intended for: | Doctoral training |